Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.

Jessica A. Kahn, Robert D. Burk, Kathleen E. Squires, Bill G. Kapogiannis, Bret Rudy, Jiahong Xu, René Gonin, Nancy Liu, Carol Worrell, Craig M. Wilson

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

The objectives of this study were to describe the prevalence and risk factors for HPV infection among HIV-infected young women receiving their first quadrivalent HPV (HPV-6, -11, -16, and -18) vaccine dose. We recruited 16- to 23-year-old women from 14 sites for an HPV vaccine trial. At the first visit, they completed a questionnaire and were tested for cervicovaginal HPV DNA (41 types) and HPV serology (4 vaccine types). Factors associated with any HPV, type-specific HPV, and high-risk (cancer-associated) HPV infections were identified using univariate and multivariable logistic regression. The mean age of participants (N = 99) was 21.4 years, 30.3% were on antiretroviral therapy, 74.7% were positive for ≥1 HPV DNA type, 53.5% for ≥1 high-risk type, 12.1% for HPV-16, and 5.1% for HPV-18. Most were HPV DNA negative and seronegative for HPV-16 (55.6%) and HPV-18 (73.7%); 45.5% were HPV DNA negative and seronegative for both HPV-16 and -18. Three variables were associated with high-risk HPV DNA in multivariable analysis: non-Hispanic black versus Hispanic ethnicity (adjusted odds ratio [AOR]: 7.06, 95% CI: 1.63 to 30.5), HIV viral load ≥ 400 versus <400 copies/mL (AOR: 3.47, 95% CI: 1.28 to 9.43), and frequency of vaginal sex in the past 90 days (AOR: 5.82, 95% CI: 1.30 to 26.11 for ≥6 vs 0 times). The prevalence of ≥1 HPV type was high in these young women, demonstrating the importance of vaccinating before sexual initiation. However, most women were HPV DNA negative and seronegative for high-risk vaccine-type HPV infection, supporting vaccination of sexually experienced HIV-positive young women.

Original languageEnglish (US)
Pages (from-to)390-399
Number of pages10
JournalJournal of acquired immune deficiency syndromes (1999)
Volume61
Issue number3
StatePublished - 2012
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.'. Together they form a unique fingerprint.

  • Cite this

    Kahn, J. A., Burk, R. D., Squires, K. E., Kapogiannis, B. G., Rudy, B., Xu, J., Gonin, R., Liu, N., Worrell, C., & Wilson, C. M. (2012). Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. Journal of acquired immune deficiency syndromes (1999), 61(3), 390-399.